Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Michael H. Le, David M. Le, Thomas C. Baez, Hansen Dang, Vy H. Nguyen, KeeSeok Lee, Christopher D. Stave, Takanori Ito, Yuankai Wu, Yee Hui Yeo, Fanpu Ji, Ramsey Cheung, Mindie H. Nguyen
Clin Mol Hepatol. 2024;30(2):235-246. Published online 2024 Jan 26 DOI: https://doi.org/10.3350/cmh.2023.0485
|
Citations to this article as recorded by
Steatotic liver disease: Know your enemies
Lung-Yi Mak
Clinical and Molecular Hepatology.2024; 30(2): 171. CrossRef Correspondence on Letter regarding “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”
Hideki Fujii, Michihiro Iwaki, Yoshihiro Kamada
Clinical and Molecular Hepatology.2024; 30(2): 281. CrossRef In response to: Steatotic liver disease-know your enemies
Michael H. Le, Linda Henry, Mindie H. Nguyen
Clinical and Molecular Hepatology.2024; 30(2): 284. CrossRef Polyphenols and terpenoids derived from Ocimum species as prospective hepatoprotective drug leads: a comprehensive mechanistic review
Amrita Chatterjee, Biswatrish Sarkar
Phytochemistry Reviews.2024;[Epub] CrossRef Treatment of Metabolic Disorders Using Novel DGAT2 Inhibitors: Pyrazolopyridine and Triazolopyridine Derivatives
Robert B. Kargbo
ACS Medicinal Chemistry Letters.2024; 15(8): 1199. CrossRef Fatty acid composition of blood serum and erythrocyte membranes in men with steatosis and steatohepatitis with normal transaminase activity
M. V. Kruchinina, M. F. Osipenko, A. A. Shestov, M. V. Parulikova
Sechenov Medical Journal.2024; 15(2): 48. CrossRef Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
Lung-Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, Kuo Chao Yew, Nobuharu Tamaki, Ruveena Bhavani Rajaram, Mara Teresa Panlilio, Rashid Lui, Hye Won Lee, Jimmy Che-To Lai, Anand V. Kulkarni, Madhumita Premkumar, Cosmas Rinaldi Adithya Lesmana, Yao Chun Hsu,
Nature Reviews Gastroenterology & Hepatology.2024;[Epub] CrossRef Cross-generational effects of dietary sea buckthorn on non-alcoholic fatty liver disease in offspring of obese female mice
Weipeng Zhang, Yonghua Shi, Yu Wang, Xuan Liu, Jianchen Yan, Haoran Chen, Junxing Zhao
Journal of Functional Foods.2024; 121: 106398. CrossRef An analysis of the burden of liver cirrhosis: Differences between the global, China, the United States and India
Keqiang Lu, Juanjuan Sui, Wenhui Yu, Yan Chen, Zhiyong Hou, Pengyan Li, Yuli Sun
Liver International.2024;[Epub] CrossRef The Predictive Value of Time‐Varying Noninvasive Scores on Long‐Term Prognosis of NAFLD in South Korea
Sung Won Chung, Min Kyung Park, Xiao Zhang, Tongtong Wang, Thomas Jemielita, Gail Fernandes, Samuel S. Engel, Heejoon Jang, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim, Xingshun Qi
Canadian Journal of Gastroenterology and Hepatology.2024;[Epub] CrossRef Equivalent prevalence and progression of chronic kidney disease in non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
Clinical and Molecular Hepatology.2024; 30(4): 962. CrossRef Reply to correspondence on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan
Clinical and Molecular Hepatology.2024; 30(4): 1039. CrossRef
|